Chimeric Antigen Receptor (CAR) T Cells With a Chlorotoxin Tumor-Targeting Domain for the Treatment of MMP2+ Recurrent or Progressive Glioblastoma

Clinical trial NCT04214392 · ACTIVE_NOT_RECRUITING

Trial details

NCT number

NCT04214392

Sponsor

City of Hope Medical Center

Status

ACTIVE_NOT_RECRUITING

Phase

Phase 1

Study type

INTERVENTIONAL

Start date

2020-02-26

Primary completion

2027-05-11

Enrollment

19

View on ClinicalTrials.gov